BR112015012411A2 - derivado de hidantoína - Google Patents

derivado de hidantoína

Info

Publication number
BR112015012411A2
BR112015012411A2 BR112015012411A BR112015012411A BR112015012411A2 BR 112015012411 A2 BR112015012411 A2 BR 112015012411A2 BR 112015012411 A BR112015012411 A BR 112015012411A BR 112015012411 A BR112015012411 A BR 112015012411A BR 112015012411 A2 BR112015012411 A2 BR 112015012411A2
Authority
BR
Brazil
Prior art keywords
hydantoin derivative
hydantoin
derivative
formula
acceptable salts
Prior art date
Application number
BR112015012411A
Other languages
English (en)
Other versions
BR112015012411B1 (pt
Inventor
Tamura Tatsuya
Esaki Toru
Nishimura Yoshikazu
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of BR112015012411A2 publication Critical patent/BR112015012411A2/pt
Publication of BR112015012411B1 publication Critical patent/BR112015012411B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Abstract

resumo patente de invenção: "derivado de hidantoína". a presente invenção provê compostos representados pela fórmula (1) abaixo e seus sais farmacologicamente aceitáveis: em que r1, r2, r3, e r4 são como definidos nas reivindicações.
BR112015012411-9A 2012-12-10 2013-12-10 Derivado de hidantoína, seu uso, composição farmacêutica e agente de mobilização de célulatronco, ou um agente para prevenção ou tratamento de doenças BR112015012411B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012269178 2012-12-10
JP2012-269178 2012-12-10
PCT/JP2013/083022 WO2014092061A1 (ja) 2012-12-10 2013-12-10 ヒダントイン誘導体

Publications (2)

Publication Number Publication Date
BR112015012411A2 true BR112015012411A2 (pt) 2017-07-11
BR112015012411B1 BR112015012411B1 (pt) 2021-10-05

Family

ID=50934349

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015012411-9A BR112015012411B1 (pt) 2012-12-10 2013-12-10 Derivado de hidantoína, seu uso, composição farmacêutica e agente de mobilização de célulatronco, ou um agente para prevenção ou tratamento de doenças

Country Status (35)

Country Link
US (5) US9428505B2 (pt)
EP (1) EP2930176B1 (pt)
JP (1) JP5951799B2 (pt)
KR (1) KR102168738B1 (pt)
CN (1) CN104854106B (pt)
AU (1) AU2013358167B2 (pt)
BR (1) BR112015012411B1 (pt)
CA (1) CA2892621C (pt)
CL (2) CL2015001391A1 (pt)
CR (1) CR20150272A (pt)
DK (1) DK2930176T3 (pt)
ES (1) ES2663797T3 (pt)
HK (1) HK1209735A1 (pt)
HR (1) HRP20180647T1 (pt)
HU (1) HUE037530T2 (pt)
IL (1) IL238277B (pt)
LT (1) LT2930176T (pt)
MA (1) MA38250B1 (pt)
MX (1) MX2015007309A (pt)
MY (1) MY178583A (pt)
NO (1) NO2930176T3 (pt)
NZ (1) NZ707946A (pt)
PE (1) PE20151295A1 (pt)
PH (1) PH12015501146B1 (pt)
PL (1) PL2930176T3 (pt)
PT (1) PT2930176T (pt)
RS (1) RS57190B1 (pt)
RU (1) RU2678984C2 (pt)
SA (1) SA515360528B1 (pt)
SG (1) SG11201504204XA (pt)
SI (1) SI2930176T1 (pt)
TW (1) TWI615394B (pt)
UA (1) UA115072C2 (pt)
WO (1) WO2014092061A1 (pt)
ZA (1) ZA201503597B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010126030A1 (ja) 2009-04-28 2010-11-04 中外製薬株式会社 スピロイミダゾロン誘導体
JP5951799B2 (ja) * 2012-12-10 2016-07-13 中外製薬株式会社 ヒダントイン誘導体
CN106572994B (zh) * 2014-06-09 2020-09-18 中外制药株式会社 含有乙内酰脲衍生物的药物组合物
WO2020027011A1 (ja) 2018-07-30 2020-02-06 中外製薬株式会社 ヒダントイン誘導体の固体分散体
CN110464002A (zh) * 2019-09-12 2019-11-19 西南石油大学 一种天然冰粉的制备方法及其应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1135470A (ja) * 1997-07-23 1999-02-09 Teijin Ltd ビタミンｄ３誘導体を含有する副甲状腺ホルモン産生促進剤
EP1137640B1 (en) 1998-12-11 2005-09-21 F. Hoffmann-La Roche Ag Cyclic hydrazine derivatives as tnf-alpha inhibitors
US7004593B2 (en) * 2002-06-06 2006-02-28 Donnelly Corporation Interior rearview mirror system with compass
US20050101574A1 (en) * 2000-08-30 2005-05-12 Seiichi Ishizuka Parathyroid hormone production inhibitors containing vitamin d3 derivatives
KR20040004412A (ko) * 2000-10-26 2004-01-13 화이자 프로덕츠 인크. 스피로-피리미딘-2,4,6-트리온 메탈로프로테이나제 억제제
SE0100902D0 (sv) 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
AR038658A1 (es) * 2001-06-15 2005-01-26 Novartis Ag Derivados de 4-aril-2(1h) quinazolinona y 4-aril-quinazolina 2-sustituidas, un proceso para su preparacion, composiciones farmaceuticas y el uso de dichos derivados para la preparacion de un medicamento
US20070099940A1 (en) * 2004-02-11 2007-05-03 Spearing Paul K Pth agonists
JP2007522215A (ja) * 2004-02-11 2007-08-09 スミスクライン・ビーチャム・コーポレイション Ｐｔｈアゴニスト
AU2005294448B2 (en) 2004-10-07 2011-07-14 Merck Sharp & Dohme Corp. CGRP receptor antagonists
WO2007135417A1 (en) 2006-05-19 2007-11-29 James Black Foundation Benzotriazepinone derivatives
MX2008016273A (es) 2006-06-20 2009-01-15 Wyeth Corp Inhibidores de canal de potasio kv1.5.
ES2351378T3 (es) 2007-06-07 2011-02-03 F. Hoffmann-La Roche Ag Derivados de prolinamida como antagonistas de nk3.
CL2008003651A1 (es) 2007-12-10 2009-06-19 Novartis Ag Compuestos derivados de 3,5-diamino-6-cloropirazinamida sustituida; composicion farmaceutica; combinacion farmaceutica; y uso en el tratamiento de una condición inflamatoria o alergica, en particular una enfermedad inflamatoria u obstructiva de las vias respiratorias.
US7981904B2 (en) 2008-03-20 2011-07-19 Takeda Pharmaceutical Company Limited Acetyl CoA carboxylase inhibitors
US8513193B2 (en) 2008-10-13 2013-08-20 University Of Rochester Protecting and repairing cartilage and musculoskeletal soft tissues
WO2010126030A1 (ja) 2009-04-28 2010-11-04 中外製薬株式会社 スピロイミダゾロン誘導体
JP5951799B2 (ja) * 2012-12-10 2016-07-13 中外製薬株式会社 ヒダントイン誘導体
CN106572994B (zh) * 2014-06-09 2020-09-18 中外制药株式会社 含有乙内酰脲衍生物的药物组合物

Also Published As

Publication number Publication date
SI2930176T1 (en) 2018-06-29
HRP20180647T1 (hr) 2018-06-01
TWI615394B (zh) 2018-02-21
IL238277A0 (en) 2015-06-30
HK1209735A1 (en) 2016-04-08
IL238277B (en) 2018-01-31
US20160326175A1 (en) 2016-11-10
AU2013358167B2 (en) 2017-09-14
PT2930176T (pt) 2018-04-03
US20220162208A1 (en) 2022-05-26
MX2015007309A (es) 2015-09-10
NZ707946A (en) 2019-11-29
RS57190B1 (sr) 2018-07-31
CN104854106A (zh) 2015-08-19
ES2663797T3 (es) 2018-04-17
PH12015501146A1 (en) 2015-08-10
RU2678984C2 (ru) 2019-02-05
EP2930176B1 (en) 2018-02-07
CR20150272A (es) 2015-07-09
EP2930176A4 (en) 2016-06-01
LT2930176T (lt) 2018-04-10
US20150274727A1 (en) 2015-10-01
MA38250A1 (fr) 2017-02-28
US9428505B2 (en) 2016-08-30
SA515360528B1 (ar) 2018-05-24
EP2930176A1 (en) 2015-10-14
US20180237436A1 (en) 2018-08-23
RU2015127624A (ru) 2017-01-16
CN104854106B (zh) 2017-07-04
CA2892621C (en) 2021-02-16
KR20150092275A (ko) 2015-08-12
MY178583A (en) 2020-10-16
NO2930176T3 (pt) 2018-07-07
BR112015012411B1 (pt) 2021-10-05
WO2014092061A1 (ja) 2014-06-19
CL2015001391A1 (es) 2015-07-31
HUE037530T2 (hu) 2018-09-28
TW201439092A (zh) 2014-10-16
JPWO2014092061A1 (ja) 2017-01-12
CA2892621A1 (en) 2014-06-19
PL2930176T3 (pl) 2018-07-31
ZA201503597B (en) 2016-09-28
AU2013358167A1 (en) 2015-04-09
UA115072C2 (uk) 2017-09-11
CL2017000069A1 (es) 2017-08-25
SG11201504204XA (en) 2015-07-30
US20210024524A1 (en) 2021-01-28
KR102168738B1 (ko) 2020-10-22
PH12015501146B1 (en) 2015-08-10
MA38250B1 (fr) 2017-10-31
PE20151295A1 (es) 2015-10-10
DK2930176T3 (en) 2018-03-19
JP5951799B2 (ja) 2016-07-13

Similar Documents

Publication Publication Date Title
BR112013025732A2 (pt) composto de imidazo-oxazina ou sal do mesmo
CR20140525A (es) Compuestos de N-alquiltriazol como antagonistas de LPAR
CR20110635A (es) Quinazolinas sustituidas como fungicidas
BR112015000704A2 (pt) imidazotriazinacarbonitrilas úteis como inibidores de quinase
UA113643C2 (xx) N-цикліламіди як нематоциди
BR112014013108A2 (pt) compostos tricíclicos fundidos como inibidores da quinase raf
BR112012030473A2 (pt) pesticidas baseados em derivados pirrolidina espiroheterocíclicos
EA201590321A1 (ru) Дейтерированный барицитиниб
BR112015002153A2 (pt) composto heterocíclico parcialmente saturado contendo nitrogênio
BR112014007193A2 (pt) derivados de pirazoloquinolinona, preparação dos mesmos e uso terapêutico dos mesmos
BR112014003587A2 (pt) derivados de 5-flúor-4-imino-3-(substituído)-3,4-di-hidropirimidin-2(1h)ona
BR112013000607A2 (pt) 5-cloro-4-hidroxi-1-metil-2-oxo-n-fenil-1,2-di-hidroquinolina-3-carboxamida, os sais e suas utilizações
PH12015501993A1 (en) Pyrazole-amide compound and medicinal uses therefor
UY33936A (es) Derivados de fluoro-piridinona útiles como agentesantibacterianos.
EA201590296A1 (ru) Дейтерированный ибрутиниб
BR112015012919A2 (pt) novos derivados de piridina
BR112013032758A2 (pt) derivados de n-oxi-pirazolo-triazepino-diona
BR112015009603A2 (pt) novos derivados de pirazina
BR112015023161A8 (pt) derivados de piridin-4-ila
CO7350640A2 (es) Compuestos diméricos
BR112015012825A2 (pt) piridopirazinas substituídas como inibidores de syk
BR112015012411A2 (pt) derivado de hidantoína
MX2014004920A (es) Nuevos derivados de pirazina.
BR112013018290A2 (pt) antagonistas de receptor 2 ativado por protease (par2)
MX2015015906A (es) Mejoras en o con relacion a compuestos organicos.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 10/12/2013, OBSERVADAS AS CONDICOES LEGAIS.